Migraine trials in South Korea
2 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
No phaseRecruitingResearch participation
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
- Where
- Ansan-si, Busan, Changwon-si, Daegu, Daejeon, Gangwon-do, Goyang, Goyang-si, Gwangju, Hwaseong, Hwaseong-si, Iksan, Incheon, Jeonju, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Yongin-si
- Age
- 19 years and over
- People
- 3,000
- Run by
- AbbVie
See details and how to joinNCT06603558Registry updated 2026-07-22
Phase 3RecruitingTrial-stage medicine
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Gangseo-gu, Hwaseong-si, Seoul
- Age
- 18 years to 45 years
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466EU 2024-517121-10-00Registry updated 2026-07-09
All Migraine trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.